US10610698B2 - Method and apparatus for controlling a laser probe - Google Patents
Method and apparatus for controlling a laser probe Download PDFInfo
- Publication number
- US10610698B2 US10610698B2 US15/027,795 US201415027795A US10610698B2 US 10610698 B2 US10610698 B2 US 10610698B2 US 201415027795 A US201415027795 A US 201415027795A US 10610698 B2 US10610698 B2 US 10610698B2
- Authority
- US
- United States
- Prior art keywords
- low level
- laser probe
- subject
- laser
- light sources
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active, expires
Links
- 239000000523 sample Substances 0.000 title claims abstract description 48
- 238000000034 method Methods 0.000 title description 16
- 238000011282 treatment Methods 0.000 claims abstract description 69
- 210000004504 adult stem cell Anatomy 0.000 claims abstract description 15
- 230000004936 stimulating effect Effects 0.000 claims abstract description 7
- 238000004590 computer program Methods 0.000 claims description 3
- 210000000130 stem cell Anatomy 0.000 description 28
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 20
- 201000010099 disease Diseases 0.000 description 18
- 210000004027 cell Anatomy 0.000 description 16
- 206010028980 Neoplasm Diseases 0.000 description 14
- 210000001519 tissue Anatomy 0.000 description 14
- 201000011510 cancer Diseases 0.000 description 9
- 230000001276 controlling effect Effects 0.000 description 9
- 210000004556 brain Anatomy 0.000 description 8
- 241000282414 Homo sapiens Species 0.000 description 7
- 238000013532 laser treatment Methods 0.000 description 7
- 230000000694 effects Effects 0.000 description 6
- 238000009168 stem cell therapy Methods 0.000 description 6
- 210000001185 bone marrow Anatomy 0.000 description 5
- 230000006378 damage Effects 0.000 description 5
- 230000001066 destructive effect Effects 0.000 description 5
- 239000000835 fiber Substances 0.000 description 5
- 208000014674 injury Diseases 0.000 description 5
- 241000124008 Mammalia Species 0.000 description 4
- 208000027418 Wounds and injury Diseases 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 238000007796 conventional method Methods 0.000 description 4
- 230000007246 mechanism Effects 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 238000009580 stem-cell therapy Methods 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 3
- ODWXUNBKCRECNW-UHFFFAOYSA-M bromocopper(1+) Chemical compound Br[Cu+] ODWXUNBKCRECNW-UHFFFAOYSA-M 0.000 description 3
- 238000002512 chemotherapy Methods 0.000 description 3
- 238000004891 communication Methods 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 230000035876 healing Effects 0.000 description 3
- 210000002569 neuron Anatomy 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 206010025323 Lymphomas Diseases 0.000 description 2
- 208000018737 Parkinson disease Diseases 0.000 description 2
- JNDMLEXHDPKVFC-UHFFFAOYSA-N aluminum;oxygen(2-);yttrium(3+) Chemical compound [O-2].[O-2].[O-2].[Al+3].[Y+3] JNDMLEXHDPKVFC-UHFFFAOYSA-N 0.000 description 2
- 230000004888 barrier function Effects 0.000 description 2
- 230000004071 biological effect Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 238000011254 conventional chemotherapy Methods 0.000 description 2
- 229940127089 cytotoxic agent Drugs 0.000 description 2
- 208000035475 disorder Diseases 0.000 description 2
- 210000004700 fetal blood Anatomy 0.000 description 2
- 230000009975 flexible effect Effects 0.000 description 2
- 210000001652 frontal lobe Anatomy 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 description 2
- 239000003102 growth factor Substances 0.000 description 2
- 210000003958 hematopoietic stem cell Anatomy 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 238000007917 intracranial administration Methods 0.000 description 2
- 208000032839 leukemia Diseases 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 210000001178 neural stem cell Anatomy 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 230000008929 regeneration Effects 0.000 description 2
- 238000011069 regeneration method Methods 0.000 description 2
- 230000008439 repair process Effects 0.000 description 2
- 230000008786 sensory perception of smell Effects 0.000 description 2
- 210000002027 skeletal muscle Anatomy 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 238000002054 transplantation Methods 0.000 description 2
- 229910019901 yttrium aluminum garnet Inorganic materials 0.000 description 2
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 208000003174 Brain Neoplasms Diseases 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- 241000282693 Cercopithecidae Species 0.000 description 1
- 208000015943 Coeliac disease Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 241000699800 Cricetinae Species 0.000 description 1
- 102000000311 Cytosine Deaminase Human genes 0.000 description 1
- 108010080611 Cytosine Deaminase Proteins 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 241000283073 Equus caballus Species 0.000 description 1
- 206010016334 Feeling hot Diseases 0.000 description 1
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 208000023105 Huntington disease Diseases 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 208000029549 Muscle injury Diseases 0.000 description 1
- 208000000112 Myalgia Diseases 0.000 description 1
- 208000012902 Nervous system disease Diseases 0.000 description 1
- 208000025966 Neurological disease Diseases 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 241000283984 Rodentia Species 0.000 description 1
- 241000282898 Sus scrofa Species 0.000 description 1
- 208000030886 Traumatic Brain injury Diseases 0.000 description 1
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 description 1
- 241000282485 Vulpes vulpes Species 0.000 description 1
- 229910000928 Yellow copper Inorganic materials 0.000 description 1
- 229910052769 Ytterbium Inorganic materials 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 229910052786 argon Inorganic materials 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 230000001363 autoimmune Effects 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 238000010241 blood sampling Methods 0.000 description 1
- 210000002798 bone marrow cell Anatomy 0.000 description 1
- 210000000621 bronchi Anatomy 0.000 description 1
- 210000001736 capillary Anatomy 0.000 description 1
- 230000021164 cell adhesion Effects 0.000 description 1
- 230000030833 cell death Effects 0.000 description 1
- 230000010267 cellular communication Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000008614 cellular interaction Effects 0.000 description 1
- 230000033077 cellular process Effects 0.000 description 1
- 210000003850 cellular structure Anatomy 0.000 description 1
- 201000004559 cerebral degeneration Diseases 0.000 description 1
- 230000001427 coherent effect Effects 0.000 description 1
- 230000001010 compromised effect Effects 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 210000004087 cornea Anatomy 0.000 description 1
- 239000000824 cytostatic agent Substances 0.000 description 1
- 230000001085 cytostatic effect Effects 0.000 description 1
- 239000002254 cytotoxic agent Substances 0.000 description 1
- 231100000599 cytotoxic agent Toxicity 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 210000003074 dental pulp Anatomy 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 231100000673 dose–response relationship Toxicity 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 210000001671 embryonic stem cell Anatomy 0.000 description 1
- KWMNWMQPPKKDII-UHFFFAOYSA-N erbium ytterbium Chemical compound [Er].[Yb] KWMNWMQPPKKDII-UHFFFAOYSA-N 0.000 description 1
- 210000003238 esophagus Anatomy 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000001508 eye Anatomy 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 230000014509 gene expression Effects 0.000 description 1
- 238000001415 gene therapy Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- CPBQJMYROZQQJC-UHFFFAOYSA-N helium neon Chemical compound [He].[Ne] CPBQJMYROZQQJC-UHFFFAOYSA-N 0.000 description 1
- 230000007124 immune defense Effects 0.000 description 1
- 230000008102 immune modulation Effects 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 230000035992 intercellular communication Effects 0.000 description 1
- 229910052743 krypton Inorganic materials 0.000 description 1
- DNNSSWSSYDEUBZ-UHFFFAOYSA-N krypton atom Chemical compound [Kr] DNNSSWSSYDEUBZ-UHFFFAOYSA-N 0.000 description 1
- 238000002647 laser therapy Methods 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- HIQSCMNRKRMPJT-UHFFFAOYSA-J lithium;yttrium(3+);tetrafluoride Chemical compound [Li+].[F-].[F-].[F-].[F-].[Y+3] HIQSCMNRKRMPJT-UHFFFAOYSA-J 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000000214 mouth Anatomy 0.000 description 1
- 210000005170 neoplastic cell Anatomy 0.000 description 1
- 208000015122 neurodegenerative disease Diseases 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- VIKNJXKGJWUCNN-XGXHKTLJSA-N norethisterone Chemical compound O=C1CC[C@@H]2[C@H]3CC[C@](C)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 VIKNJXKGJWUCNN-XGXHKTLJSA-N 0.000 description 1
- 210000001331 nose Anatomy 0.000 description 1
- 210000004248 oligodendroglia Anatomy 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 210000003899 penis Anatomy 0.000 description 1
- 210000004303 peritoneum Anatomy 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 229940002612 prodrug Drugs 0.000 description 1
- 239000000651 prodrug Substances 0.000 description 1
- 230000002062 proliferating effect Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 210000002307 prostate Anatomy 0.000 description 1
- 238000001959 radiotherapy Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 210000001525 retina Anatomy 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 239000010979 ruby Substances 0.000 description 1
- 229910001750 ruby Inorganic materials 0.000 description 1
- 229910052594 sapphire Inorganic materials 0.000 description 1
- 239000010980 sapphire Substances 0.000 description 1
- 239000004065 semiconductor Substances 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 210000000278 spinal cord Anatomy 0.000 description 1
- 238000002660 stem cell treatment Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 229910019655 synthetic inorganic crystalline material Inorganic materials 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000003867 tiredness Effects 0.000 description 1
- 208000016255 tiredness Diseases 0.000 description 1
- 230000030968 tissue homeostasis Effects 0.000 description 1
- 210000003437 trachea Anatomy 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 230000009529 traumatic brain injury Effects 0.000 description 1
- 210000003708 urethra Anatomy 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 210000001215 vagina Anatomy 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 238000001429 visible spectrum Methods 0.000 description 1
- 230000037314 wound repair Effects 0.000 description 1
- NAWDYIZEMPQZHO-UHFFFAOYSA-N ytterbium Chemical compound [Yb] NAWDYIZEMPQZHO-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0613—Apparatus adapted for a specific treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/067—Radiation therapy using light using laser light
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0626—Monitoring, verifying, controlling systems and methods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0635—Radiation therapy using light characterised by the body area to be irradiated
- A61N2005/0643—Applicators, probes irradiating specific body areas in close proximity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0658—Radiation therapy using light characterised by the wavelength of light used
- A61N2005/0659—Radiation therapy using light characterised by the wavelength of light used infrared
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0658—Radiation therapy using light characterised by the wavelength of light used
- A61N2005/0662—Visible light
-
- A61N2005/067—
Definitions
- stem cells For instance, in the small intestine there are perhaps up to 10 stem cells at the bottom of the crypt out of a total crypt population of ⁇ 300 cells.
- satellite (stem) cells comprise about 5% of all nuclei, but in the bone marrow the multi-potential hematopoietic stem cell is much rarer, with a frequency of perhaps 1 in 10000 amongst all bone marrow cells.
- stem cells In skeletal muscle, satellite (stem) cells comprise about 5% of all nuclei, but in the bone marrow the multi-potential hematopoietic stem cell is much rarer, with a frequency of perhaps 1 in 10000 amongst all bone marrow cells.
- the conditions to grow or simply ‘select’ stem cells in vitro do not exist for many tissues where it is accepted that the stem cells simply fail to grow due to lack of required
- Stem cells may also be used to treat brain degeneration, such as in Parkinson's and Alzheimer's disease.
- Therapeutic lasers used in medicine for instance for stem cell therapy, generally fall into two categories: non-destructive, low-energy lasers, also referred to as “cold lasers” designed to generate largely thermal biological effects in tissue, and destructive lasers designed to selectively damage or destroy tissue.
- a therapist who performs a low level laser treatment has many years of experience and must know where to apply radiation to tissue and how much to apply, for example, with respect to the power of the laser measured in milliwatts (mW), and which wavelength of light is most suitable for different types of treatment. This may be troublesome since there is often a need for sufficiently trained and experienced therapists. Even a very experienced therapist may suffer from sufficient training and experience to be able to control the laser probe properly.
- mW milliwatts
- FIG. 2 b is a bottom view of the low level laser probe per se.
- a first stage of a typical laser treatment in this case of MS, is to treat the spine.
- the region between vertebrae is treated with 2,500 mW for 5 minutes.
- the region from C 1 to the sacrum is treated with 5,000 mW for 5 minutes, and a further 5 minutes from C 1 to the sacrum with 2,500 mW.
- the patient thereafter lies on his or her back for treatment of the frontal lobe from temple to temple with 5,000 mW for 4 minutes.
- Each laser treatment takes approximately 30-45 minutes. Typically, the first ten treatments should be carried out at a frequency of two times per week. Noticeable results of the treatments normally arise after approximately 8-10 treatments.
- Appropriate laser light sources for the method of the invention can include but are not limited to krypton (416 nanometers (nm)), argon (488 and 515 nm), copper bromide (510 and 578 nm), helium-neon (544, 594 and 612 nm), neodymium-doped yttrium aluminum garnet (532 and 1064 nm), ruby (628 and 694 nm), titanium-sapphire (700-1000 nm), neodymium-doped yttrium lithium fluoride (1047 and 1053 nm), erbium-glass (1540 nm), and helium-doped fluoride (2950 nm).
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Pathology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Radiation-Therapy Devices (AREA)
- Laser Surgery Devices (AREA)
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE1351180A SE538469C2 (sv) | 2013-10-07 | 2013-10-07 | Anordning för styrning av en laserprob |
SE1351180 | 2013-10-07 | ||
SE1351180-3 | 2013-10-07 | ||
PCT/SE2014/051162 WO2015053694A2 (fr) | 2013-10-07 | 2014-10-07 | Procédé et appareil pour commander une sonde laser |
Publications (2)
Publication Number | Publication Date |
---|---|
US20160228724A1 US20160228724A1 (en) | 2016-08-11 |
US10610698B2 true US10610698B2 (en) | 2020-04-07 |
Family
ID=52813717
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US15/027,795 Active 2035-03-18 US10610698B2 (en) | 2013-10-07 | 2014-10-07 | Method and apparatus for controlling a laser probe |
Country Status (7)
Country | Link |
---|---|
US (1) | US10610698B2 (fr) |
EP (1) | EP3055023B1 (fr) |
CN (1) | CN105682738B (fr) |
DK (1) | DK3055023T3 (fr) |
ES (1) | ES2746276T3 (fr) |
SE (1) | SE538469C2 (fr) |
WO (1) | WO2015053694A2 (fr) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10202598B2 (en) | 2014-05-30 | 2019-02-12 | Todd Frank Ovokaitys | Methods and systems for generation, use, and delivery of activated stem cells |
WO2015184421A1 (fr) | 2014-05-30 | 2015-12-03 | Ovokaitys Todd Frank | Procédé et système de génération et d'utilisation de cellules souches activées |
US10040728B2 (en) | 2014-06-06 | 2018-08-07 | Todd Frank Ovokaitys | Methods and compositions for increasing the bioactivity of nutrients |
US10384985B2 (en) | 2014-06-06 | 2019-08-20 | B.K. Consultants, Inc. | Methods and compositions for increasing the yield of, and beneficial chemical composition of, certain plants |
CN108310674B (zh) * | 2017-12-21 | 2019-08-13 | 宁波大学 | 一种用于光动力治疗的光源 |
KR20230038556A (ko) * | 2020-07-21 | 2023-03-20 | 데이진 화-마 가부시키가이샤 | 광선 조사 장치 |
Citations (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0320080A1 (fr) | 1987-11-13 | 1989-06-14 | Omega Universal Limited | Dispositif pour stimulation biologique de tissus |
WO2001021256A1 (fr) | 1999-09-20 | 2001-03-29 | Susanne Johansson | Sonde a laser pour traitement medical |
US20010041884A1 (en) * | 1996-11-25 | 2001-11-15 | Frey Rudolph W. | Method for determining and correcting vision |
US20020002391A1 (en) | 1999-03-29 | 2002-01-03 | Gerdes Harold M. | Method and apparatus for therapeutic laser treatment |
US20040030370A1 (en) | 2002-08-05 | 2004-02-12 | Lytle Larry Robert | Therapeutic low level laser apparatus and method |
US20060184214A1 (en) | 1998-11-30 | 2006-08-17 | Light Bioscience, Llc | Low intensity light therapy for treatment of retinal, macular, and visual pathway disorders |
US20070208395A1 (en) * | 2005-10-05 | 2007-09-06 | Leclerc Norbert H | Phototherapy Device and Method of Providing Phototherapy to a Body Surface |
US20070213792A1 (en) * | 2002-10-07 | 2007-09-13 | Palomar Medical Technologies, Inc. | Treatment Of Tissue Volume With Radiant Energy |
CN101267845A (zh) | 2005-07-21 | 2008-09-17 | 诺密尔医药技术公司 | 近红外除菌激光系统(nimels) |
US20090299441A1 (en) | 2002-08-28 | 2009-12-03 | Nomir Medical Technologies, Inc. | Near Infrared Microbial Elimination Laser Systems (NIMEL) |
US20110060266A1 (en) | 2001-11-01 | 2011-03-10 | Photothera, Inc. | Enhanced stem cell therapy and stem cell production through the administration of low level light energy |
US20110144725A1 (en) | 2009-12-11 | 2011-06-16 | Bwt Property, Inc. | Phototherapy Apparatus With Interactive User Interface |
US20110178583A1 (en) | 2010-01-14 | 2011-07-21 | Yonatan Gerlitz | Scanning mechanism and treatment method for lllt or other light source therapy device |
CN102844075A (zh) | 2011-02-01 | 2012-12-26 | 保罗·威世博 | 标量激光治疗装置 |
CN102905750A (zh) | 2010-05-14 | 2013-01-30 | 皇家飞利浦电子股份有限公司 | 用于使用两个或更多波长段的电磁辐射给受试者提供光疗的系统 |
WO2013120095A1 (fr) | 2012-02-10 | 2013-08-15 | Nomir Medical Technologies | Amélioration par des infrarouges proches de la coordination cellulaire spatiotemporelle circadienne et ultradienne dans le système intégumentaire humain |
US20130344560A1 (en) | 2007-04-30 | 2013-12-26 | Jon Weston | Method for localized photo-irradiation of biological tissues to stimulate tissue regeneration or repair |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2572976T3 (es) * | 2003-07-31 | 2016-06-03 | Gentlewaves Llc | Sistema y método para el tratamiento fotodinámico de la piel |
EP2066403B1 (fr) * | 2006-08-15 | 2010-05-12 | Spectracure AB | Système et procédé pour commander et régler les paramètres de photothérapie dynamique interstitielle |
US8211099B2 (en) * | 2007-01-31 | 2012-07-03 | Tyco Healthcare Group Lp | Thermal feedback systems and methods of using the same |
US20090210039A1 (en) * | 2007-05-09 | 2009-08-20 | Boyden Edward S | Prosthetic system for therapeutic optical activation and silencing of genetically-targeted neurons |
US20110125226A1 (en) * | 2009-11-26 | 2011-05-26 | Larry Lytle | Coordinated delivery of soliton waves through coupled medical instruments |
WO2012082739A2 (fr) * | 2010-12-14 | 2012-06-21 | Joanna Vargas | Appareil de photothérapie à diodes électroluminescentes |
CN102406980B (zh) * | 2011-06-17 | 2014-03-12 | 武汉海纳川科技有限公司 | 一种智能激光治疗仪 |
-
2013
- 2013-10-07 SE SE1351180A patent/SE538469C2/sv unknown
-
2014
- 2014-10-07 US US15/027,795 patent/US10610698B2/en active Active
- 2014-10-07 WO PCT/SE2014/051162 patent/WO2015053694A2/fr active Application Filing
- 2014-10-07 EP EP14852679.1A patent/EP3055023B1/fr active Active
- 2014-10-07 ES ES14852679T patent/ES2746276T3/es active Active
- 2014-10-07 DK DK14852679.1T patent/DK3055023T3/da active
- 2014-10-07 CN CN201480058952.7A patent/CN105682738B/zh active Active
Patent Citations (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0320080A1 (fr) | 1987-11-13 | 1989-06-14 | Omega Universal Limited | Dispositif pour stimulation biologique de tissus |
US20010041884A1 (en) * | 1996-11-25 | 2001-11-15 | Frey Rudolph W. | Method for determining and correcting vision |
US20060184214A1 (en) | 1998-11-30 | 2006-08-17 | Light Bioscience, Llc | Low intensity light therapy for treatment of retinal, macular, and visual pathway disorders |
US20020002391A1 (en) | 1999-03-29 | 2002-01-03 | Gerdes Harold M. | Method and apparatus for therapeutic laser treatment |
WO2001021256A1 (fr) | 1999-09-20 | 2001-03-29 | Susanne Johansson | Sonde a laser pour traitement medical |
US6755820B1 (en) * | 1999-09-20 | 2004-06-29 | Susanne Johansson | Laser probe for medical treatment |
US20110060266A1 (en) | 2001-11-01 | 2011-03-10 | Photothera, Inc. | Enhanced stem cell therapy and stem cell production through the administration of low level light energy |
US20040030370A1 (en) | 2002-08-05 | 2004-02-12 | Lytle Larry Robert | Therapeutic low level laser apparatus and method |
US20090299441A1 (en) | 2002-08-28 | 2009-12-03 | Nomir Medical Technologies, Inc. | Near Infrared Microbial Elimination Laser Systems (NIMEL) |
US20070213792A1 (en) * | 2002-10-07 | 2007-09-13 | Palomar Medical Technologies, Inc. | Treatment Of Tissue Volume With Radiant Energy |
CN101267845A (zh) | 2005-07-21 | 2008-09-17 | 诺密尔医药技术公司 | 近红外除菌激光系统(nimels) |
US20070208395A1 (en) * | 2005-10-05 | 2007-09-06 | Leclerc Norbert H | Phototherapy Device and Method of Providing Phototherapy to a Body Surface |
US20130344560A1 (en) | 2007-04-30 | 2013-12-26 | Jon Weston | Method for localized photo-irradiation of biological tissues to stimulate tissue regeneration or repair |
US20110144725A1 (en) | 2009-12-11 | 2011-06-16 | Bwt Property, Inc. | Phototherapy Apparatus With Interactive User Interface |
US20110178583A1 (en) | 2010-01-14 | 2011-07-21 | Yonatan Gerlitz | Scanning mechanism and treatment method for lllt or other light source therapy device |
CN102811768A (zh) | 2010-01-14 | 2012-12-05 | 米哈尔·施洛瑟 | 用于lllt或其它光源疗法的扫描机构和治疗方法 |
CN102905750A (zh) | 2010-05-14 | 2013-01-30 | 皇家飞利浦电子股份有限公司 | 用于使用两个或更多波长段的电磁辐射给受试者提供光疗的系统 |
CN102844075A (zh) | 2011-02-01 | 2012-12-26 | 保罗·威世博 | 标量激光治疗装置 |
WO2013120095A1 (fr) | 2012-02-10 | 2013-08-15 | Nomir Medical Technologies | Amélioration par des infrarouges proches de la coordination cellulaire spatiotemporelle circadienne et ultradienne dans le système intégumentaire humain |
Non-Patent Citations (4)
Title |
---|
Extended European Search Report for corresponding Patent Application No. 14852679.1 dated Apr. 13, 2017. |
International Search Report for corresponding Swedish Patent Application No. PCT/SE2014/051162 dated Apr. 1, 2015. |
Office Action for corresponding Chinese Patent Application No. 201480058952.7 dated Feb. 5, 2018. |
Office Action for corresponding Chinese Patent Application No. 201480058952.7 dated Jun. 2, 2017. |
Also Published As
Publication number | Publication date |
---|---|
DK3055023T3 (da) | 2019-09-23 |
WO2015053694A2 (fr) | 2015-04-16 |
CN105682738B (zh) | 2019-03-19 |
SE1351180A1 (sv) | 2015-04-08 |
WO2015053694A3 (fr) | 2015-06-04 |
CN105682738A (zh) | 2016-06-15 |
EP3055023A2 (fr) | 2016-08-17 |
ES2746276T3 (es) | 2020-03-05 |
EP3055023A4 (fr) | 2017-05-17 |
SE538469C2 (sv) | 2016-07-12 |
US20160228724A1 (en) | 2016-08-11 |
EP3055023B1 (fr) | 2019-06-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10610698B2 (en) | Method and apparatus for controlling a laser probe | |
Hennessy et al. | Photobiomodulation and the brain: a new paradigm | |
Moro et al. | Photobiomodulation inside the brain: a novel method of applying near-infrared light intracranially and its impact on dopaminergic cell survival in MPTP-treated mice | |
US9649507B2 (en) | Low level laser therapy for Alzheimer's disease | |
Johnstone et al. | The potential of light therapy in Parkinson's disease | |
US10758739B2 (en) | Restructuring neural pathways in the brain with a combination of transcranial therapies | |
Houreld et al. | Effectiveness of helium-neon laser irradiation on viability and cytotoxicity of diabetic-wounded fibroblast cells | |
Pryor | Advances in Laser Therapy for the treatment of work related injuries | |
US9162076B2 (en) | Method for tissue regeneration or degeneration in human and an apparatus therefore | |
Moskvin et al. | Low-level laser therapy for sports horses | |
US20240108912A1 (en) | Methods of Using Light Energy to Facilitate Oxidative Phosphorylation | |
Park et al. | A new approach to urinary bladder control with optogenetics | |
Manole et al. | The effects of exogenous modulation on the peripheral nerve regeneration after injury and primary surgical repair | |
TW202041243A (zh) | 成癮症放射治療系統 | |
Collins | Transcranial Stimulation Appears Safe and Tolerable for Stroke, Pilot Trial Suggests | |
Buzza | SELECTIVE INHIBITION OF SMALL-DIAMETER NERVE FIBERS THROUGH PHOTOBIOMODULATION: DOSING, BEHAVIORAL ANALYSES, AND MECHANISTIC INSIGHTS | |
RU2236270C2 (ru) | Способ лечения злокачественных опухолей головного мозга с мультифокальным характером роста | |
Bassma et al. | The electronics and magnitics fields in the human body | |
Coffman et al. | tDCS and Cognitive Training for Treatment of Schizophrenia Symptoms | |
Sliney et al. | Special Lectures | |
Nelson Marquina PhD | 10 Energy Medicine | |
CN111888657A (zh) | 成瘾症放射治疗系统 | |
Baltzer | Therapeutic lasers in small animals. | |
Johnstone | The potential of light therapy in Parkinson’s | |
RU2294736C1 (ru) | Способ рукина воздействия на биологически активные точки при рефлексотерапии дисфункции печени и устройство для его осуществления |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STPP | Information on status: patent application and granting procedure in general |
Free format text: FINAL REJECTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NOTICE OF ALLOWANCE MAILED -- APPLICATION RECEIVED IN OFFICE OF PUBLICATIONS |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: PUBLICATIONS -- ISSUE FEE PAYMENT RECEIVED |
|
STCF | Information on status: patent grant |
Free format text: PATENTED CASE |
|
MAFP | Maintenance fee payment |
Free format text: PAYMENT OF MAINTENANCE FEE, 4TH YR, SMALL ENTITY (ORIGINAL EVENT CODE: M2551); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY Year of fee payment: 4 |